- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07902414
Mi2000 TICI Follow-up (M2FU)
This Post-Market Clinical Follow-up (PMCF) investigation aims to further collect evidence on safety and performance of the Mi2000 TICI. This PMCF investigation will collect retrospective and prospective clinical data from the use of the Mi2000 TICI and related devices.
This PMCF investigation is performed on a new cochlear implant system, which was previously studied in two pre-market clinical investigations with limited follow-up duration. The purpose of the current clinical investigation is to collect further evidence by collecting clinical data on the use of the Mi2000 TICI.
The Mi2000 TICI is a state-of-the-art cochlear implant, designed to be totally implantable, indicated to treat severe to profound hearing loss, asymmetric hearing loss and single-sided deafness.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This PMCF investigation will collect data on the long term use of the Mi2000 TICI retrospectively and prospectively.
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Florian Schwarze, PhD
- Telefonnummer: +4357788
- E-post: studies@medel.com
Studieorter
-
-
-
Liège, Belgien, 4000
- Har inte rekryterat ännu
- Centre Hospitalier Universitaire de Liège, Department ORL
-
Kontakt:
- Philippe Lefebvre, Prof. Dr.
- E-post: pp.lefebvre@uliege.be
-
-
Belgium
-
Antwerp, Belgium, Belgien, 2650
- Har inte rekryterat ännu
- UZA Antwerpen
-
Kontakt:
- Vincent van Rompaey, Prof. Dr.
- Telefonnummer: vincent.vanrompaey@uza.be
-
-
-
-
-
Nadarzyn, Polen, 05-830
- Har inte rekryterat ännu
- The Institute of Physiology and Pathology of Hearing
-
Kontakt:
- Piotr Skarzynski, Prof. Dr.
- E-post: p.skarzynski@csim.pl
-
-
-
-
Bavaria
-
München, Bavaria, Tyskland, 81377
- Rekrytering
- Klinikum der Universität München, Campus Großhadern
-
Kontakt:
- Joachim Müller, Prof. Dr.
- E-post: Joachim.Mueller@med.uni-muenchen.de
-
Würzburg, Bavaria, Tyskland, 97080
- Har inte rekryterat ännu
- Universitätsklinikum Würzburg
-
Kontakt:
- Anja Kurz, Dr.
- E-post: Kurz_A@ukw.de
-
-
-
-
State of Vienna
-
Vienna, State of Vienna, Österrike, 1090
- Har inte rekryterat ännu
- AKH Wien
-
Kontakt:
- Christoph Arnoldner, Prof. Dr.
- E-post: christoph.arnoldner@meduniwien.ac.at
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
This clinical investigation aims to enrol participants of previous clinical investigations, implanted with the Mi2000 TICI UNICO.
Beskrivning
Inclusion Criteria:
- Recipient of an Mi2000 TICI in one of the pre-market studies
- Signed and dated informed consent before the start of any study-specific procedure
Exclusion Criteria:
-
Lack of compliance with any inclusion criterion
-
Anything that, in the opinion of the Investigator, would
- place the subject at increased risk
- preclude the subject's full compliance with or completion of the study
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: OTHER
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Mi2000 TICI UNICO recipients
Recipients of a MED-EL Mi2000 TICI UNICO in a previous clinical investigation. |
Participants in this clinical investigation received a totally implantable cochlear implant and will be followed-up for an extended period of time. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Word Test in Quiet
Tidsram: Pre-op to 36 months after first fitting
|
Word recognition in quiet, on a scale from 0 to 100% correct, higher scores indicate better outcomes |
Pre-op to 36 months after first fitting
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Nijmegen Cochlear Implant Questionnaire (NCIQ)
Tidsram: Pre-op to 36 months after first fitting
|
Disease specific Quality of Life, overall score is on a scale from 0 to 100, higher numbers indicating better outcomes |
Pre-op to 36 months after first fitting
|
|
Speech, Spatial, Quality of Hearing (SSQ12)
Tidsram: Pre-op to 36 months after first fitting
|
Speech, Spatial and Quality of hearing scale from 0 to 10, higher numbers indicating better outcomes |
Pre-op to 36 months after first fitting
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Word test in quiet
Tidsram: through study completion, an average of 60 months after first fitting
|
Word recognition in quiet, on a scale from 0 to 100% correct, higher scores indicate better outcomes |
through study completion, an average of 60 months after first fitting
|
|
Sentence Test in Noise
Tidsram: through study completion, an average of 60 months after first fitting
|
Oldenburg Matrix Test, results measured in dB signal-to-noise ratio (SNR) with a range of +30 to -10 dB SNR, lower values indicating better outcomes |
through study completion, an average of 60 months after first fitting
|
|
Health Utility Index Mark 3 (HUI3)
Tidsram: through study completion, an average of 60 months after first fitting
|
Health utility scale: 1.00: Perfect health. 0.00: Death. Negative values: States worse than death. |
through study completion, an average of 60 months after first fitting
|
|
Nijmegen Cochlear Implant Questionnaire (NCIQ)
Tidsram: through study completion, an average of 60 months after first fitting
|
Disease specific Quality of Life, overall score is on a scale from 0 to 100, higher numbers indicating better outcomes |
through study completion, an average of 60 months after first fitting
|
|
Speech, Spatial, Quality of Hearing (SSQ12)
Tidsram: through study completion, an average of 60 months after first fitting
|
Speech, Spatial and Quality of hearing scale from 0 to 10, higher numbers indicating better outcomes |
through study completion, an average of 60 months after first fitting
|
|
Hearing Implant Sound Quality Index (HISQUI)
Tidsram: through study completion, an average of 60 months after first fitting
|
Sound quality score ranging from 19 (very poor sound quality) to 133 (very good sound quality) |
through study completion, an average of 60 months after first fitting
|
|
Tinnitus functional index (TFI)
Tidsram: through study completion, an average of 60 months after first fitting
|
Tinnitus questionnaire measures the severity and negative impact of tinnitus on a 0 (Not a Problem / Slight Tinnitus) to 100 (Very Big Problem / Very Severe Tinnitus) scale |
through study completion, an average of 60 months after first fitting
|
|
Audiogram
Tidsram: through study completion, an average of 60 months after first fitting
|
Pure-tone air-conduction hearing thresholds will be measured in each ear. The threshold is the lowest sound level, in decibels hearing level (dB HL), at which the participant responds. The outcome is the threshold at each frequency. Higher thresholds mean poorer hearing; lower thresholds better hearing. |
through study completion, an average of 60 months after first fitting
|
Samarbetspartners och utredare
Utredare
- Studierektor: Florian Schwarze, MED-EL
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Neurologiska manifestationer
- Sjukdomar i nervsystemet
- Otorhinolaryngologiska sjukdomar
- Sensationsstörningar
- Öronsjukdomar
- Hörselstörningar
- Patologiska tillstånd, tecken och symtom
- Tecken och symtom
- Hörselnedsättning
- Kirurgiska ingrepp, operativ
- Protesimplantation
- Otorhinolaryngologiska kirurgiska ingrepp
- Otologiska kirurgiska ingrepp
- Cochlearimplantation
Andra studie-ID-nummer
- MED-EL_CRD_2025_04
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .